Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
F 9.510 -1.45% -0.140
BHC closed down 1.45 percent on Thursday, May 9, 2024, on 1.57 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness -1.45%
Multiple of Ten Bearish Other -1.45%
Below Lower BB Weakness -1.45%
Down 3 Days in a Row Weakness -1.45%

   Recent Intraday Alerts

Alert Time
Down 2% about 9 hours ago
Possible NR7 about 11 hours ago
Down 1% about 11 hours ago
Rose Above Lower Bollinger Band about 13 hours ago
Fell Below Previous Day's Low about 15 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bausch Health Companies Inc. Description

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health S&P/Tsx 60 Index Medicine Pharma Pharmaceutical Biotechnology Pharmaceuticals Pharmaceutical Products Laser Medical Devices Contact Lens Ulcer Aes Dermatology Psoriasis Acne Actinic Keratosis Atopic Dermatitis Colitis Hair Removal Keratosis Over The Counter Products Specialty Drugs Ulcerative Colitis

Is BHC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.43
52 Week Low 7.56
Average Volume 420,995
200-Day Moving Average 11.179
50-Day Moving Average 12.368
20-Day Moving Average 11.400
10-Day Moving Average 10.949
Average True Range 0.523
RSI (14) 20.63
ADX 28.44
+DI 15.656
-DI 37.071
Chandelier Exit (Long, 3 ATRs) 11.921
Chandelier Exit (Short, 3 ATRs) 10.959
Upper Bollinger Bands 13.066
Lower Bollinger Band 9.733
Percent B (%b) -0.07
BandWidth 29.231
MACD Line -0.688
MACD Signal Line -0.457
MACD Histogram -0.231
Fundamentals Value
Market Cap 3.38 Billion
Num Shares 355 Million
EPS -2.61
Price-to-Earnings (P/E) Ratio -3.64
Price-to-Sales 0.84
Price-to-Book 11.59
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.005
Resistance 3 (R3) 10.020 9.870 9.923
Resistance 2 (R2) 9.870 9.744 9.863 9.895
Resistance 1 (R1) 9.690 9.666 9.615 9.675 9.867
Pivot Point 9.540 9.540 9.503 9.533 9.540
Support 1 (S1) 9.360 9.414 9.285 9.345 9.153
Support 2 (S2) 9.210 9.336 9.203 9.125
Support 3 (S3) 9.030 9.210 9.098
Support 4 (S4) 9.015